The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model

The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model

Abstract Background During 2020–21, the United States used a multifaceted approach to control SARS-CoV-2 (Covid-19) and reduce mortality and morbidity. This included non-medical interventions (NMIs), aggressive vaccine development and deployment, and research into more effective approaches to medica...

Full description

Bibliographic Details
Main Authors: Adam J. Atherly, Eline M. van den Broek-Altenburg
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Health Services Research
Subjects:
Covid-19
Cost-effectiveness
Non-medical interventions
Vaccines
Susceptible-Infected-Recovered model
Incremental cost effectiveness
Online Access:https://doi.org/10.1186/s12913-023-09282-1

Internet

https://doi.org/10.1186/s12913-023-09282-1

Similar Items